Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
The Impact of Treatment on Serum Level of Procalcitonin in Patients with Active Pulmonary Tuberculosis
oleh: Hassan Ghobadi, Shahrzad M. Lari, Firouz Amani, Shahram Habibzadeh, Farhad Pourfarzi
Format: | Article |
---|---|
Diterbitkan: | Mashhad University of Medical Sciences 2014-11-01 |
Deskripsi
Introduction: About one third of the world's population is infected with tuberculosis (TB) and each year, about 1.5 to 2 million people die from TB. Procalcitonin (PCT) is an inflammatory marker that its level has variable results. There are some discussions in the utilization of PCT as a diagnostic marker in active pulmonary TB. The aim of this study was to compare serum PCT before and after treatment in patients with pulmonary TB. Materials and Methods: This conducted on patients with pulmonary TB. Data were collected using a check list. The serum level of PCT was measured by ELISA test at the beginning and after six months of treatment. All data were analyzed using SPSS 16. Results: Forty-two patients with active pulmonary TB entered in this study. The mean age of the patients was 45.48 ± 12.54 years and 54.8% of them were male. Most of the patients (59.5 %) were rural inhabitants. There was a family history of TB in 26% of patients. The most common symptom (45.2%) was cough. Mean PCT prior to treatment was 1.25 ± 0.98 ng/ml. and 81% of the patients had PCT higher than 0.5 to 5. After treatment PCT level reduced significantly (P